Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: Involvement of PDGFRB and response to imatinib

Blood

Volumn 102, Issue 12, 2003, Pages 4187-4190

  Wilkinson, Kathryn ^b   Velloso, Elvira R P ^b   Lopes, Luiz Fernando ^b   Lee, Charles ^b   Aster, Jon C ^b   Shipp, Margaret A ^b   Aguiar, Ricardo C T ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; ETOPOSIDE; IMATINIB; INTERFERON; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CASE REPORT; CHROMOSOME 5Q; CHROMOSOME TRANSLOCATION; CYTOGENETICS; EOSINOPHILIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTERPHASE; MOLECULAR CLONING; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR UPREGULATION; SCHOOL CHILD;

EID: 0344826038     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-04-1150     Document Type: Article

References (23)

1. Mauro MJ, O'Dwyer M, Heinrich MC, Druker BJ. STI571: a paradigm of new agents for cancer therapeutics. J Clin Oncol. 2002;20:325-334.
2. Macdonald D, Aguiar RC, Mason PJ, Goldman JM, Cross NCP. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia. 1995;9:1628-1630.
3. Aguiar RC, Chase A, Coulthard S, et al. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement. Blood. 1997;90:3130-3135.
4. Steer EJ, Gross NCP. Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor beta. Acta Haematol. 2002;107:113-122.
5. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 1994;77:307-316.
6. Ross TS, Bernard OA, Berger R, Gilliland DG. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood. 1998;91:4419-4426.
7. Schwaller J, Anastasiadou E, Cain D, et al. H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22). Blood. 2001;97:3910-3918.
8. Abe A, Emi N, Tanimoto M, Terasaki H, Marunouchi T, Saito H. Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. Blood. 1997;90:4271-4277.
9. Magnusson MK, Meade KE, Brown KE, et al. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor b receptor in chronic myelomonocytic leukemia. Blood. 2001;98:2518-2525.
10. Cools J, DeAngelo D, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348:1201-1214.
11. Darbyshire PJ, ShortLand D, Swansbury GJ, Sadler J, Lawler SD, Chessells JM. A myeloproliferative disease in two infants associated with eosinophilia and chromosome t(1;5) translocation. Br J Haematol. 1987;66:483-486.
12. Luciano L, Catalano L, Sarrantonio C, Guerriero A, Califano C, Rotoli B. AlphalFN-induced hematologic and cytogenetic remission in chronic eosinophilic leukemia with t(1;5). Haematologica. 1999;84:651-653.
13. Aguiar R, Yakushijin Y, Kharbanda S, Tiwari S, Freeman G, Shipp M. PTPROt: an alternatively spliced and developmentally regulated B-lymphoid phosphatase that promotes GO/G1 arrest. Blood. 1999;94:2403-2413.
14. Koenderman L, Kok PT, Hamelink ML, Verhoeven AJ, Bruijnzeel PL. An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals. J Leukoc Biol. 1988;44:79-86.
15. Verde I, Pahlke G, Salanova M, et al. Myomegalin is a novel protein of the golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase. J Biol Chem. 2001;276:11189-11198.
16. Perez-Losada A, Woessner S, Sole F, Florensa L, Granena A. Refractory anaemia with hypereosinophilia and clonal abnormal metaphases detected only in the neutrophilic granulopoietic series. Acta Haematol. 1994;91:80-83.
17. Kobayashi H, Kitano K, Shimodaira S, et al. Eosinophilia in myelodysplastic syndrome with a (12;21)(q23;q22) translocation. Cancer Genet Cytogenet. 1993;68:95-98.
18. Jani K, Kempski HM, Reeves BR. A case of myelodysplasia with eosinophilia having a translocation t(5;12)(q31;q13) restricted to myeloid cells but not involving eosinophils. Br J Haematol. 1994;87:57-60.
19. Weide R, Rieder H, Mehraein Y, et al. Chronic eosinophilic leukaemia (CEL): a distinct myeloproliferative disease. Br J Haematol. 1997;96:117-123.
20. Weil GJ, Chused TM. Eosinophil autofluorescence and its use in isolation and analysis of human eosinophils using flow microfluorometry. Blood. 1981;57:1099-1104.
21. Carulli G, Sbrana S, Azzara A, et al. Detection of eosinophils in whole blood samples by flow cytometry. Cytometry. 1998;34:272-279.
22. Magnusson MK, Meade KE, Nakamura R, Barrett J, Dunbar CE. Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene. Blood. 2002;100:1088-1091.
23. Apperley JF, Gardembas M, Melo JV, et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med. 2002;347:481-448.